{"id":"https://openalex.org/W2932379030","doi":"https://doi.org/10.1001/jamaneurol.2019.0447","title":"Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy","display_name":"Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy","publication_year":2019,"publication_date":"2019-04-01","ids":{"openalex":"https://openalex.org/W2932379030","doi":"https://doi.org/10.1001/jamaneurol.2019.0447","mag":"2932379030","pmid":"https://pubmed.ncbi.nlm.nih.gov/30933252","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6583056"},"language":"en","primary_location":{"id":"doi:10.1001/jamaneurol.2019.0447","doi":"https://doi.org/10.1001/jamaneurol.2019.0447","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaneurol.2019.0447","pdf_url":"https://jamanetwork.com/journals/jamaneurology/articlepdf/2729013/jamaneurology_kim_2019_oi_190013.pdf","source":{"id":"https://openalex.org/S164389565","display_name":"JAMA Neurology","issn_l":"2168-6149","issn":["2168-6149","2168-6157"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://jamanetwork.com/journals/jamaneurology/articlepdf/2729013/jamaneurology_kim_2019_oi_190013.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100724837","display_name":"Hyunmi Kim","orcid":"https://orcid.org/0000-0003-2459-7836","observed_orcids":["https://orcid.org/0000-0003-2459-7836"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hyunmi Kim","raw_affiliation_strings":["Department of Neurology, Stanford University School of Medicine, Palo Alto, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Stanford University School of Medicine, Palo Alto, California","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015461885","display_name":"Edward Faught","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Faught","raw_affiliation_strings":["Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016590840","display_name":"David J. Thurman","orcid":"https://orcid.org/0000-0002-0533-7062","observed_orcids":["https://orcid.org/0000-0002-0533-7062"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J. Thurman","raw_affiliation_strings":["Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018935336","display_name":"Jesse Fishman","orcid":"https://orcid.org/0009-0002-8729-7435","observed_orcids":["https://orcid.org/0009-0002-8729-7435"]},"institutions":[{"id":"https://openalex.org/I4210127098","display_name":"UCB Pharma (United States)","ror":"https://ror.org/028qka468","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127098","https://openalex.org/I85722119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jesse Fishman","raw_affiliation_strings":["UCB Pharma, Smyrna, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Smyrna, Georgia","institution_ids":["https://openalex.org/I4210127098"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086622773","display_name":"Linda Kalilani","orcid":"https://orcid.org/0000-0003-2820-0875","observed_orcids":["https://orcid.org/0000-0003-2820-0875"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linda Kalilani","raw_affiliation_strings":["UCB Pharma, Raleigh, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Raleigh, North Carolina","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5100724837"],"corresponding_institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"],"apc_list":null,"apc_paid":null,"fwci":6.9708,"has_fulltext":true,"cited_by_count":45,"citation_normalized_percentile":{"value":0.97432231,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"76","issue":"7","first_page":"783","last_page":"783"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.7505000233650208,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.7505000233650208,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.24619999527931213,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.925000011920929},{"id":"https://openalex.org/keywords/women-of-reproductive-age","display_name":"women of reproductive age","score":0.8840000033378601},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.972000002861023},{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.8410000205039978},{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":0.996999979019165},{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":0.8460000157356262},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.7459999918937683},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.5049999952316284},{"id":"https://openalex.org/keywords/seizure-types","display_name":"seizure types","score":0.5820000171661377},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.878000020980835},{"id":"https://openalex.org/keywords/pregnancy-risk","display_name":"pregnancy risk","score":0.4129999876022339},{"id":"https://openalex.org/keywords/focal-epilepsy","display_name":"focal epilepsy","score":0.414000004529953},{"id":"https://openalex.org/keywords/generalized-epilepsy","display_name":"generalized epilepsy","score":0.9950000047683716},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.38600000739097595},{"id":"https://openalex.org/keywords/health-insurance-claims","display_name":"health insurance claims","score":0.5210000276565552},{"id":"https://openalex.org/keywords/medicaid","display_name":"Medicaid","score":0.5540000200271606},{"id":"https://openalex.org/keywords/medicare","display_name":"Medicare","score":0.7889999747276306},{"id":"https://openalex.org/keywords/private-insurance","display_name":"private insurance","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.853803277015686},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.8291833400726318},{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.7702739238739014},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5940196514129639},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.5887443423271179},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5665223598480225},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5256763100624084},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4649319350719452},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.4551536738872528},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.44921165704727173},{"id":"https://openalex.org/C2994127763","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Antiepileptic drug","level":3,"score":0.44003331661224365},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.43501579761505127},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24800220131874084},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.15852555632591248},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.07435169816017151},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077213","descriptor_name":"Lamotrigine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077236","descriptor_name":"Topiramate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077287","descriptor_name":"Levetiracetam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000078330","descriptor_name":"Oxcarbazepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004213","descriptor_name":"Dissociative Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004828","descriptor_name":"Epilepsies, Partial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004828","descriptor_name":"Epilepsies, Partial","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004829","descriptor_name":"Epilepsy, Generalized","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004829","descriptor_name":"Epilepsy, Generalized","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012306","descriptor_name":"Risk","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013723","descriptor_name":"Teratogens","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015897","descriptor_name":"Comorbidity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019964","descriptor_name":"Mood Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D020773","descriptor_name":"Headache Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1001/jamaneurol.2019.0447","doi":"https://doi.org/10.1001/jamaneurol.2019.0447","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaneurol.2019.0447","pdf_url":"https://jamanetwork.com/journals/jamaneurology/articlepdf/2729013/jamaneurology_kim_2019_oi_190013.pdf","source":{"id":"https://openalex.org/S164389565","display_name":"JAMA Neurology","issn_l":"2168-6149","issn":["2168-6149","2168-6157"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Neurology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6583056","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6583056","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Neurol","raw_type":"Text"},{"id":"pmid:30933252","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30933252","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA neurology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1001/jamaneurol.2019.0447","doi":"https://doi.org/10.1001/jamaneurol.2019.0447","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaneurol.2019.0447","pdf_url":"https://jamanetwork.com/journals/jamaneurology/articlepdf/2729013/jamaneurology_kim_2019_oi_190013.pdf","source":{"id":"https://openalex.org/S164389565","display_name":"JAMA Neurology","issn_l":"2168-6149","issn":["2168-6149","2168-6157"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Neurology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2932379030.pdf","grobid_xml":"https://content.openalex.org/works/W2932379030.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W1604539019","https://openalex.org/W1967986271","https://openalex.org/W1969259810","https://openalex.org/W1975807583","https://openalex.org/W1976799394","https://openalex.org/W1983142641","https://openalex.org/W2010628201","https://openalex.org/W2049898930","https://openalex.org/W2060374695","https://openalex.org/W2069864252","https://openalex.org/W2086130827","https://openalex.org/W2097747862","https://openalex.org/W2102393666","https://openalex.org/W2110695090","https://openalex.org/W2111091028","https://openalex.org/W2111716786","https://openalex.org/W2117487291","https://openalex.org/W2119186079","https://openalex.org/W2124416664","https://openalex.org/W2127577164","https://openalex.org/W2143374288","https://openalex.org/W2145602055","https://openalex.org/W2146629358","https://openalex.org/W2148147266","https://openalex.org/W2161574720","https://openalex.org/W2163842154","https://openalex.org/W2165865661","https://openalex.org/W2167158873","https://openalex.org/W2171069034","https://openalex.org/W2274016697","https://openalex.org/W2306843755","https://openalex.org/W2463500278","https://openalex.org/W2586570485","https://openalex.org/W2590864569","https://openalex.org/W2616967758","https://openalex.org/W2621707691","https://openalex.org/W2621735612","https://openalex.org/W2759873827","https://openalex.org/W2778077806","https://openalex.org/W2799646619","https://openalex.org/W2800992563","https://openalex.org/W2808405323","https://openalex.org/W2886691768","https://openalex.org/W2895161048","https://openalex.org/W3109666218","https://openalex.org/W4232908185","https://openalex.org/W4252511024"],"related_works":["https://openalex.org/W2353520101","https://openalex.org/W2808260620","https://openalex.org/W2010628201","https://openalex.org/W2901139602","https://openalex.org/W2987416009","https://openalex.org/W2799646619","https://openalex.org/W4293195685","https://openalex.org/W3215605955","https://openalex.org/W4390842188","https://openalex.org/W2972875358"],"abstract_inverted_index":{"Importance:":[0],"Limited":[1],"population-based":[2],"data":[3,74],"are":[4],"available":[5],"on":[6],"antiepileptic":[7],"drug":[8,182],"(AED)":[9],"treatment":[10,31,183,265],"patterns":[11,32],"in":[12,36,223],"women":[13,46,79,222,377,446],"of":[14,38,47,119,138,274,385,390,397,402,412,417,434,439],"childbearing":[15,48],"age":[16,49],"with":[17,50,80,127,378,427,451],"epilepsy;":[18],"the":[19,29,151,193,224],"current":[20],"population":[21],"risk":[22],"is":[23],"not":[24,267],"clear.":[25],"Objectives:":[26],"To":[27],"examine":[28],"AED":[30,148,264],"and":[33,41,54,65,97,130,157,161,171,174,179,189,209,259,285,300,345,368,405,407,443,453],"identify":[34,76],"differences":[35],"use":[37],"valproate":[39,452],"sodium":[40],"topiramate":[42,346,454],"by":[43,167],"comorbidities":[44],"among":[45,243],"epilepsy.":[51,314,370],"Design,":[52],"Setting,":[53],"Participants:":[55],"A":[56],"retrospective":[57],"cohort":[58,90],"study":[59,89],"used":[60,296,311],"a":[61,136],"nationwide":[62],"commercial":[63],"database":[64],"supplemental":[66],"Medicare":[67],"as":[68,70,240],"well":[69],"Medicaid":[71],"insurance":[72],"claims":[73],"to":[75,84,109,186,448],"46":[77,194],"767":[78,195],"epilepsy":[81,125,145,163,226,299],"aged":[82],"15":[83],"44":[85],"years.":[86],"The":[87],"eligible":[88],"was":[91,103,266,308,372,421],"enrolled":[92],"between":[93],"January":[94,106],"1,":[95,107],"2009,":[96],"December":[98],"31,":[99],"2013.":[100],"Data":[101],"analysis":[102],"conducted":[104],"from":[105],"2017,":[108],"February":[110],"22,":[111],"2018.":[112],"Exposures:":[113],"Cases":[114],"required":[115,135],"an":[116,144],"International":[117],"Classification":[118],"Diseases,":[120],"Ninth":[121],"Revision,":[122],"Clinical":[123],"Modification-coded":[124],"diagnosis":[126,146],"continuous":[128],"medical":[129],"pharmacy":[131],"enrollment.":[132],"Incident":[133],"cases":[134,202,213,258],"baseline":[137],"2":[139],"or":[140,147,234,272,381,430],"more":[141,273,294,309,373,422],"years":[142],"without":[143],"prescription":[149],"before":[150],"index":[152],"date.":[153],"For":[154],"both":[155,366],"incident":[156,201,225,257],"prevalent":[158,212,247,262],"cases,":[159,248,263],"focal":[160,313,367],"generalized":[162,298,369],"cohorts":[164],"were":[165,199,293,361],"matched":[166],"age,":[168,205,216],"payer":[169],"type,":[170],"enrollment":[172],"period":[173],"then":[175],"compared.":[176],"Main":[177],"Outcomes":[178],"Measures:":[180],"Antiepileptic":[181],"pattern":[184],"according":[185],"seizure":[187],"type":[188],"comorbidities.":[190],"Results:":[191],"Of":[192],"patients":[196],"identified,":[197],"there":[198],"8003":[200],"(mean":[203,214],"[SD]":[204,215],"27.3":[206],"[9.4]":[207],"years)":[208],"38":[210],"764":[211],"29.7":[217],"[9.0]":[218],"years).":[219],"Among":[220],"3219":[221],"group":[227],"who":[228],"received":[229,238,252],"AEDs":[230,363,464],"for":[231,297,312,365,376,425],"90":[232],"days":[233,271],"more,":[235],"3173":[236],"(98.6%)":[237],"monotherapy":[239],"first-line":[241],"treatment;":[242],"28":[244],"239":[245],"treated":[246,450],"18":[249],"987":[250],"(67.2%)":[251],"monotherapy.":[253],"In":[254],"3544":[255],"(44.3%)":[256],"9480":[260],"(24.5%)":[261],"documented":[268],"during":[269],"180":[270],"follow-up":[275],"after":[276],"diagnosis.":[277],"Valproate":[278,371],"(incident:":[279,287,302,316,331,347,383,395,410,432],"35":[280],"[5.81%];":[281],"prevalent:":[282,290,305,323,338,354,388,400,415,437],"514":[283],"[13.1%])":[284],"phenytoin":[286],"33":[288],"[5.48%];":[289],"178":[291],"[4.53%])":[292],"commonly":[295,374],"oxcarbazepine":[301],"53":[303,384],"[8.03%];":[304],"386":[306],"[9.89%])":[307],"often":[310],"Levetiracetam":[315],"focal,":[317,324,332,339,348,355],"267":[318],"[40.5%];":[319],"generalized,":[320,327,335,342,351,358],"271":[321],"[45.0%];":[322],"794":[325],"[20.3%];":[326],"871":[328,343],"[22.2%]),":[329,344],"lamotrigine":[330],"123":[333],"[18.6%];":[334],"106":[336],"[17.6%];":[337],"968":[340],"[24.8%];":[341],"102":[349],"[15.5%];":[350],"64":[352],"[10.6%];":[353],"499":[356],"[12.8%];":[357],"470":[359],"[12.0%])":[360],"leading":[362],"prescribed":[364,375,424],"comorbid":[379,428],"headache":[380,429],"migraine":[382,431],"1251":[386,435],"[4.2%];":[387],"839":[389],"8046":[391,440],"[10.4%]),":[392],"mood":[393],"disorder":[394],"63":[396],"860":[398],"[7.3%];":[399],"1110":[401],"6995":[403],"[15.9%]),":[404],"anxiety":[406],"dissociative":[408],"disorders":[409],"57":[411],"881":[413],"[6.5%];":[414],"798":[416],"5912":[418],"[13.5%]).":[419],"Topiramate":[420],"likely":[423],"those":[426],"335":[433],"[26.8%];":[436],"2322":[438],"[28.9%]).":[441],"Conclusions":[442],"Relevance:":[444],"Many":[445],"appear":[447],"be":[449],"despite":[455,465],"known":[456],"teratogenicity":[457,467],"risks.":[458,468],"Comorbidities":[459],"may":[460],"affect":[461],"selecting":[462],"certain":[463],"their":[466]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-04-11T00:00:00"}